Invivo Therapeutics Holdings (NVIV) has released an update to notify the public and investors about its debt resolution strategies.
InVivo Therapeutics Holdings Corp. and its subsidiary filed for Chapter 11 bankruptcy on February 1, 2024, in the Delaware District Court. The company plans to continue operations during the bankruptcy process and has submitted requests to the Court to maintain business operations and potentially sell its assets. Information about the bankruptcy proceedings can be found on the website administered by Kurtzman Carson Consultants LLC.
For further insights into NVIV financials, check out TipRanks’ Financials page.
For a comprehensive understanding of the announcement, you can read the full document here.
